VERAXA Biotech Appoints Carl von Halem as Interim CFO
July 13, 2026 — VERAXA Biotech appoints Carl von Halem as interim CFO, succeeding Torsten Bürgermeister. The company is finalizing a permanent CFO to support growth in antibody-based therapeutics.